Viemed Healthcare reports Q3 net revenue of $71.9 million and net income of $3.5 million

Reuters11-06
<a href="https://laohu8.com/S/VMD">Viemed Healthcare</a> reports Q3 net revenue of $71.9 million and net income of $3.5 million

Viemed Healthcare Inc. reported net revenues of $71.9 million for the quarter ended September 30, 2025, an increase of 24.0% or $13.9 million over the same period in 2024. Net income attributable to Viemed for the quarter was $3.5 million, or $0.09 per diluted share. Adjusted EBITDA reached $16.1 million, up 15.5% compared to the prior year quarter. Net cash provided by operating activities was $18.4 million for the quarter, with free cash flow of $12.4 million. During the period, Viemed completed the acquisition of Lehan's Medical Equipment on July 1, 2025, which was immediately accretive to net income and earnings per share. The company completed its 2025 share repurchase program and updated its adjusted EBITDA guidance for the year to a range of $60.0 million to $62.0 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viemed Healthcare Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1097432) on November 05, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment